The Antifungal Drugs market accounted to US$ 10,182.3 Mn in 2018 and is expected to grow at a CAGR of 3.2% during the forecast period 2019 – 2027, to account to US$ 13,524.2 Mn by 2027.
Global Antifungal Drugs market was segmented by infection type, drug type, therapeutic indication, and dosage form. On the basis of the infection type, the market is segmented as superficial fungal infection and systemic antifungal infection. Based on the drug type, the Antifungal Drugs market is segmented into echinocandins, azoles, polyenes, allylamines, and others. On the basis of the therapeutic indication, the Antifungal Drugs market is segmented into aspergillosis, dermatophytosis, candidiasis, and others. By dosage form, the market is segmented into drugs, ointment, powder, and others.
Get Sample PDF:
https://www.theinsightpartners.com/sample/TIPRE00003745/
The market for Antifungal Drugs is expected to grow significantly due to factors such as rising incidences for the fungal infection of the skin, nails and hair, increasing incidences of cancers, HIV, and hospital-acquired infections and favorable government initiatives to combat the antifungal diseases are likely to drive the growth of the Antifungal Drugs market. However, lack of awareness regarding the fungal infections may restrict the growth of Antifungal Drugs market.
Buy Now: https://www.theinsightpartners.com/buy/TIPRE00003745/
The report segments the global Antifungal Drugs market as follows:
Global Antifungal Drugs Market – By Infection Type
• Superficial Fungal Infection
• Systemic Fungal Infection
Global Antifungal Drugs Market – By Drug Type
• Echinocandins
• Azoles
• Polyenes
• Allylamines
• Others
Global Antifungal Drugs Market – By Therapeutic Indication
• Aspergillosis
• Dermatophytosis
• Candidiasis
• Others
Global Antifungal Drugs Market – By Dosage Form
• Drugs
• Ointment
• Powder
• Others
Global Antifungal Drugs Market – By Geography
• North America
o U.S
o Canada
o Mexico
• Europe
o France
o Germany
o U.K
o Italy
o Spain
• Asia Pacific
o China
o India
o Japan
o Australia
o South Korea
• Middle East & Africa
o Saudi Arabia
o UAE
o South Africa
• South & Central America
o Brazil
o Argentina
Company Profiles
• Pfizer Inc.
• Sanofi S.A.
• Gilead Sciences, Inc.
• Merck And Co., Inc.
• Scynexis Inc.
• Novartis International AG
• Abbott Laboratories
• Bayer AG
• Glenmark Pharmaceutical
• Glaxosmithkline Plc.
About Us:
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.
Contact Us:
If you have any queries about this report or if you would like further information, please contact us:
Contact Person: Sameer Joshi
E-mail: sales@theinsightpartners.com
Phone: +1-646-491-9876